IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma cells.

AIM The insulin-like growth factor 1 (IGF1) gene gives rise to multiple transcripts, using an elaborate alternative splicing mechanism. The aim of this study was to shed light on the expression and role of the IGF1 system in human MG-63 osteoblast-like osteosarcoma cells. MATERIALS AND METHODS The expression of the IGF1Ea, IGF1Eb and IGF1Ec isoforms was characterized using reverse transcription polymerase chain reaction (RT-PCR), quantitative real time-PCR (qRT-PCR) and western blot analysis. Using trypan blue exclusion assays, we also examined the mitogenic effects of IGF1 and of a synthetic peptide related to the E domain of IGF1Ec (synthetic E peptide) on MG-63 cells, as well as on MG-63 cells which had been molecularly modified to restrain the expression of type I IGF receptor (IGF1R) and of insulin receptor (INSR) by siRNA techniques (IGF1R KO or INSR KO MG-63 cells). RESULTS MG-63 cells express only the IGF1Ea and IGF1Ec transcripts. Exogenous administration of dihydrotestosterone (DHT) significantly increased the expression of IGF1Ea and IGF1Ec mRNA and it induced the previously undetectable expression of IGF1Eb transcript. Exogenous administration of IGF1, insulin and the synthetic E peptide stimulated the growth of MG-63 cells, while only E peptide stimulated the growth of IGF1R KO and INSR KO MG-63 cells. CONCLUSION These data suggest that the expression of all IGF1 isoforms is hormonally regulated in MG-63 cells and that the expression of IGF1Ec may be involved in osteosarcoma biology by generating the Ec peptide which acts via an IGF1R-independent and INSR-independent mechanism.

[1]  M. Moschos,et al.  Expression of the insulin-like growth factor 1 (IGF-1) and type I IGF receptor mRNAs in human HLE-B3 lens epithelial cells. , 2011, In vivo.

[2]  M. Koutsilieris,et al.  uPA, uPAR and TGFβ₁ expression during early and late post myocardial infarction period in rat myocardium. , 2010, In vivo.

[3]  A. Sereno,et al.  Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response , 2010, Molecular Cancer Therapeutics.

[4]  C. Petraki,et al.  Preferential expression of IGF‐1Ec (MGF) transcript in cancerous tissues of human prostate: Evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells , 2010, The Prostate.

[5]  K. Janeway,et al.  Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. , 2010, The Lancet. Oncology.

[6]  E. Kolb,et al.  Past, present and future of therapies in pediatric sarcomas. , 2010, Future oncology.

[7]  R. Kurzrock,et al.  A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors , 2010, Clinical Cancer Research.

[8]  A. Belfiore,et al.  Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. , 2009, Endocrine reviews.

[9]  P. Houghton,et al.  The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma. , 2009, Cancer research.

[10]  M. Koutsilieris,et al.  Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. , 2009, In vivo.

[11]  Apostolos Papalois,et al.  IGF-1 Expression in Infarcted Myocardium and MGF E Peptide Actions in Rat Cardiomyocytes in Vitro , 2009, Molecular medicine.

[12]  R. Osborne.  Commercial interest waxes for IGF-1 blockers , 2008, Nature Biotechnology.

[13]  A. Adjei,et al.  Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors , 2007, Clinical Cancer Research.

[14]  D. Ludwig,et al.  IMC-A12, a Human IgG1 Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor , 2007, Clinical Cancer Research.

[15]  A. Tolcher,et al.  Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Bacci,et al.  Primary bone osteosarcoma in the pediatric age: state of the art. , 2006, Cancer treatment reviews.

[17]  Yuan-Liang Wang,et al.  The stress reaction and its molecular events: splicing variants. , 2004, Biochemical and biophysical research communications.

[18]  G. Goldspink,et al.  Expression and Splicing of the Insulin‐Like Growth Factor Gene in Rodent Muscle is Associated with Muscle Satellite (stem) Cell Activation following Local Tissue Damage , 2003, The Journal of physiology.

[19]  M. Spiteri,et al.  Differential mRNA expression of insulin-like growth factor-1 splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. , 2001, American journal of respiratory and critical care medicine.

[20]  N. Levi.  Incidence of osteosarcoma, chondrosarcoma and Ewing's sarcoma in east Denmark: Reverse male to female ratio in osteosarcoma , 1998, European Journal of Orthopaedic Surgery & Traumatology.

[21]  I. Andrulis,et al.  Expression of insulin‐like growth factor receptor, IGF‐1, and IGF‐2 in primary and metastatic osteosarcoma , 1998, Journal of surgical oncology.

[22]  M. Koutsilieris,et al.  Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor beta 1 in MG‐63 human osteosarcoma cells , 1995, International journal of cancer.

[23]  S. Chew,et al.  An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. , 1995, Endocrinology.

[24]  B. Riggs,et al.  Transforming Growth Factor-β and Forskolin Increase All Classes of Insulin-like Growth Factor-I Transcripts in Normal Human Osteoblast-like Cells , 1995 .

[25]  S. Hirschfeld,et al.  Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. , 1994, Cancer research.

[26]  H. von Holst,et al.  Characterization of insulin-like growth factor 1 in human primary brain tumors. , 1993, Cancer research.

[27]  E. Canalis,et al.  Growth factors and the regulation of bone remodeling. , 1988, The Journal of clinical investigation.

[28]  M. Koutsilieris,et al.  Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype. , 1987, The Journal of clinical investigation.

[29]  A. Philippou,et al.  Insulinlike Growth Factor-1Ec (MGF) Expression in Eutopic and Ectopic Endometrium: Characterization of the MGF E-Peptide Actions In Vitro , 2011, Molecular medicine.

[30]  P. Houghton,et al.  Fully Human Monoclonal Antibody Targeting IGF-1 R , Is Effective Alone and in Combination With Rapamycin in Inhibiting Growth of Osteosarcoma Xenografts , 2010 .

[31]  M. Koutsilieris,et al.  Characterization of a rabbit antihuman mechano growth factor (MGF) polyclonal antibody against the last 24 amino acids of the E domain. , 2008, In vivo.

[32]  Robert A. Brown,et al.  Mechanical signals and IGF‐I gene splicing in vitro in relation to development of skeletal muscle , 2005, Journal of cellular physiology.

[33]  I. Andrulis,et al.  Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. , 1995, Cancer research.